Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe Record History page shows a new revision entry v3.3.2 and the removal of the previous revision v3.3.1.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays Revision: v3.3.1 replacing the previous v3.2.0, indicating a backend/system update that does not change study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the banner about government funding status from the page, which previously warned that updates may be delayed due to appropriations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check69 days agoChange DetectedThe new screenshot shows updates to the record history with no substantive changes to the current trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange Detected- Added a government funding notice about potential service disruptions and where to check status, plus a link to cc.nih.gov and opm.gov. - Updated version from v3.0.2 to v3.2.0.SummaryDifference12%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.